HEALTHCARE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST
2024-11-27 | Pages: 200+ | Report ID: BYR-163615 | Healthcare
Historical data: 2018 - 2023
Forecast period: 2024 - 2031
Quantitative units: Revenue in USD million and CAGR from 2024 to 2031
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Healthcare Contract Research Organization (CRO) Market
1.1 SCOPE OF THE REPORT
1.2 MARKET SEGMENT ANALYSIS
1.3 REGULATORY SCENARIO BY REGION/COUNTRY
1.4 MARKET INVESTMENT SCENARIO STRATEGIC
1.5 MARKET ANALYSIS BY TYPE (USD MILLION)
1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)
2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
2.1.1 MARKET DRIVER ANALYSIS
2.1.2 MARKET RESTRAINT ANALYSIS
2.1.3 MARKET OPPORTUNITY
2.1.4 MARKET CHALLENGES
3.1 INDUSTRY TRENDS
3.1.1 SWOT ANALYSIS
3.1.2 PESTEL ANALYSIS
3.1.3 PORTER’S FIVE FORCES ANALYSIS
3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4.1 COVID-19 ANALYSIS
5.1 GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET, SALES AREA, TYPE
5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET
7.1 GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE AND SHARE (2018-2031) (USD MILLION)
8.1 GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
8.2 GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
9.1 GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
9.2 GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
10.1 GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)
10.2 GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)
11.1 NORTH AMERICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
11.2 NORTH AMERICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
11.3 NORTH AMERICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
11.4 NORTH AMERICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
11.5 NORTH AMERICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
11.6 NORTH AMERICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
12.1 EUROPE HEALTHCARE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
12.2 EUROPE HEALTHCARE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
12.3 EUROPE HEALTHCARE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
12.4 EUROPE HEALTHCARE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
12.5 EUROPE HEALTHCARE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
12.6 EUROPE HEALTHCARE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
13.1 ASIA PACIFIC HEALTHCARE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
13.2 ASIA PACIFIC HEALTHCARE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
13.3 ASIA PACIFIC HEALTHCARE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
13.4 ASIA PACIFIC HEALTHCARE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
13.5 ASIA PACIFIC HEALTHCARE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
13.6 ASIA PACIFIC HEALTHCARE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
14.1 LATIN AMERICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>
14.2 LATIN AMERICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
14.3 LATIN AMERICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
14.4 LATIN AMERICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
14.5 LATIN AMERICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
14.6 LATIN AMERICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
15.1 MIDDLE EAST & AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
15.2 MIDDLE EAST & AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
15.3 MIDDLE EAST & AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
15.4 MIDDLE EAST & AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
15.5 MIDDLE EAST & AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
15.6 MIDDLE EAST & AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>
16.1 IQVIA
16.1.1 COMPANY DETAILS
16.1.2 FINANCIALS (USD MILLION)
16.1.3 PRODUCT SUMMARY
16.1.4 RECENT DEVELOPMENTS
16.2 Covance Inc.
16.3 Pharmaceutical Product Development, LLC (PPD)
16.4 PAREXEL
16.5 Charles River Laboratories
16.6 ICON, plc.
16.7 Medidata Solutions, Inc.
16.8 Syneos Health.
16.9 Pharmaron.
16.10 GVK Biosciences Private Limited.
18.1 METHODOLOGY
18.2 RESEARCH DATA SOURCE
18.2.1 SECONDARY DATA
18.2.2 KEY DATA FROM SECONDARY
18.2.3 PRIMARY DATA
18.2.4 KEY DATA FROM PRIMARY
18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
18.2.6 MARKET ESTIMATION
18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
18.2.8 LEGAL DISCLAIMER
Market Segments
By TypeDrug Discovery
 o Target validation
 o Lead identification
 o Lead optimization
Pre-Clinical
Clinical
 o Phase I Trial Services
 o Phase II Trial Services
 o Phase III Trial Services
 o Phase IV Trial Services
By Service
Project Management/Clinical Supply Management
Data Management
Regulatory/Medical Affairs
Medical Writing
Clinical Monitoring
Quality Management/ Assurance
Bio-statistics
Investigator Payments
Laboratory
Patient and site Recruitment
Technology
Others
Companies
IQVIA
Covance Inc.
Pharmaceutical Product Development, LLC (PPD)
PAREXEL
Charles River Laboratories
ICON, plc.
Medidata Solutions, Inc.
Syneos Health.
Pharmaron.
GVK Biosciences Private Limited.
BROWSE INDUSTRY
- PROACTIVE
- QUALITY & RELIABILITY
- GLOBAL OUTREACH
- COMPETITIVE PRICING
WHY CHOOSE US
We manage our resources 24/7 to identify issues and address them before they become problems.
We are committed to providing reliable and highly accurate data with an excellent quality control system.
6 Major regions and 40+ countries level analysis accomplished.
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.